Wird geladen...

A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee.

Lornoxicam is a new non-steroidal anti-inflammatory agent (NSAID) with a similar pharmacological profile to other oxicams and a potency 10 times greater than piroxicam. A multicentre, randomised, double blind, parallel group study was undertaken to compare the efficacy and tolerance of four weeks�...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Berry, H, Bird, H A, Black, C, Blake, D R, Freeman, A M, Golding, D N, Hamilton, E B, Jayson, M I, Kidd, B, Kohn, H
Format: Artigo
Sprache:Inglês
Veröffentlicht: 1992
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005665/
https://ncbi.nlm.nih.gov/pubmed/1550410
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!